These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 16756418

  • 1. A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine.
    Gross A, Marsch LA, Badger GJ, Bickel WK.
    Exp Clin Psychopharmacol; 2006 May; 14(2):148-56. PubMed ID: 16756418
    [Abstract] [Full Text] [Related]

  • 2. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients.
    Higgins ST, Heil SH, Dantona R, Donham R, Matthews M, Badger GJ.
    Addiction; 2007 Feb; 102(2):271-81. PubMed ID: 17222282
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients.
    Oliveto A, Poling J, Sevarino KA, Gonsai KR, McCance-Katz EF, Stine SM, Kosten TR.
    Drug Alcohol Depend; 2005 Aug 01; 79(2):157-65. PubMed ID: 16002025
    [Abstract] [Full Text] [Related]

  • 4. Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine.
    Chopra MP, Landes RD, Gatchalian KM, Jackson LC, Buchhalter AR, Stitzer ML, Marsch LA, Bickel WK.
    Exp Clin Psychopharmacol; 2009 Aug 01; 17(4):226-36. PubMed ID: 19653788
    [Abstract] [Full Text] [Related]

  • 5. Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial.
    Chawarski MC, Mazlan M, Schottenfeld RS.
    Drug Alcohol Depend; 2008 Apr 01; 94(1-3):281-4. PubMed ID: 18164145
    [Abstract] [Full Text] [Related]

  • 6. Effects of voucher-based intervention on abstinence and retention in an outpatient treatment for cocaine addiction: a randomized controlled trial.
    Garcia-Rodriguez O, Secades-Villa R, Higgins ST, Fernandez-Hermida JR, Carballo JL, Errasti Perez JM, Al-halabi Diaz S.
    Exp Clin Psychopharmacol; 2009 Jun 01; 17(3):131-8. PubMed ID: 19586227
    [Abstract] [Full Text] [Related]

  • 7. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.
    Arch Gen Psychiatry; 2005 Oct 01; 62(10):1157-64. PubMed ID: 16203961
    [Abstract] [Full Text] [Related]

  • 8. Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing.
    Marsch LA, Bickel WK, Badger GJ, Jacobs EA.
    Drug Alcohol Depend; 2005 Feb 14; 77(2):195-204. PubMed ID: 15664721
    [Abstract] [Full Text] [Related]

  • 9. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS, Chawarski MC, Pakes JR, Pantalon MV, Carroll KM, Kosten TR.
    Am J Psychiatry; 2005 Feb 14; 162(2):340-9. PubMed ID: 15677600
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness.
    Sigmon SC, Higgins ST.
    J Subst Abuse Treat; 2006 Jun 14; 30(4):291-5. PubMed ID: 16716843
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs.
    Silverman K, Robles E, Mudric T, Bigelow GE, Stitzer ML.
    J Consult Clin Psychol; 2004 Oct 14; 72(5):839-54. PubMed ID: 15482042
    [Abstract] [Full Text] [Related]

  • 15. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.
    McKay JR, Lynch KG, Shepard DS, Pettinati HM.
    Arch Gen Psychiatry; 2005 Feb 14; 62(2):199-207. PubMed ID: 15699297
    [Abstract] [Full Text] [Related]

  • 16. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, Martell B, Kosten TR.
    Arch Gen Psychiatry; 2006 Feb 14; 63(2):219-28. PubMed ID: 16461866
    [Abstract] [Full Text] [Related]

  • 17. Cocaine abstinence during methadone maintenance: effects of repeated brief exposure to voucher-based reinforcement.
    Sigmon SC, Correia CJ, Stitzer ML.
    Exp Clin Psychopharmacol; 2004 Nov 14; 12(4):269-75. PubMed ID: 15571444
    [Abstract] [Full Text] [Related]

  • 18. Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans.
    Foltin RW, Fischman MW.
    J Pharmacol Exp Ther; 1996 Sep 14; 278(3):1153-64. PubMed ID: 8819498
    [Abstract] [Full Text] [Related]

  • 19. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct 14; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

  • 20. A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence.
    Petry NM, Bickel WK, Badger GJ.
    Clin Pharmacol Ther; 1999 Sep 14; 66(3):306-14. PubMed ID: 10511067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.